Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Stockley

Showing results (81-90 of 117) with videos related to

Pageof 12
Sort By:
Journal of Personalized Medicine|September 28, 2021
Should Age-Dependent Absolute Risk Thresholds Be Used for Risk Stratification in Risk-Stratified Breast Cancer Screening?Nora Pashayan, Antonis C Antoniou, Andrew Lee, et al.
Lung Cancer (Amsterdam, Netherlands)|May 15, 2025
Prognostic and predictive effects of TP53 co-mutation in patients with non-small cell lung cancer with rare treatable driver mutationsJamie Feng, Katrina Hueniken, Zhen Jason Fan, et al.
BMC Genomics|April 30, 2015
Whole-exome analysis of foetal autopsy tissue reveals a frameshift mutation in OBSL1, consistent with a diagnosis of 3-M SyndromeChristian R Marshall, Sandra A Farrell, Donna Cushing, et al.
Current Oncology (Toronto, Ont.)|August 28, 2024
Repeat Next-Generation Sequencing (15-Gene Panel) in Unifocal, Synchronous, and Metachronous Non-Small-Cell Lung Cancer-A Single-Center ExperienceShelley Kuang, Kaitlin Chen, Sachin Sayal, et al.
Plos One|December 1, 2021
Genomic characterization of non-schistosomiasis-related squamous cell carcinoma of the urinary bladder: A retrospective exploratory studyEsmail M Al-Ezzi, Zachary W Veitch, Samer H Salah, et al.
International Journal of Cancer|September 12, 2017
Identifying actionable variants using next generation sequencing in patients with a historical diagnosis of undifferentiated pleomorphic sarcomaJeremy Lewin, Swati Garg, Beatrice Y Lau, et al.
BMC Medical Genomics|August 11, 2018
Additional germline findings from a tumor profiling programNeda Stjepanovic, Tracy L Stockley, Philippe L Bedard, et al.
Current Oncology (Toronto, Ont.)|May 15, 2023
Consensus Recommendations to Optimize the Detection and Reporting of <i>NTRK</i> Gene Fusions by RNA-Based Next-Generation SequencingTracy L Stockley, Bryan Lo, Adrian Box, et al.
Breast Cancer Research and Treatment|November 28, 2017
Impact of multi-gene mutational profiling on clinical trial outcomes in metastatic breast cancerRossanna C Pezo, Tom W Chen, Hal K Berman, et al.
Journal of Medical Genetics|December 23, 2022
Development of a comprehensive approach to adult hereditary cancer testing in OntarioKathleen Anne Bell, Raymond Kim, Melyssa Aronson, et al.
Pageof 12

Showing results (81-90 of 117) with videos related to

Sort By:
Pageof 12
Journal of Personalized Medicine|September 28, 2021
Should Age-Dependent Absolute Risk Thresholds Be Used for Risk Stratification in Risk-Stratified Breast Cancer Screening?Nora Pashayan, Antonis C Antoniou, Andrew Lee, et al.
Lung Cancer (Amsterdam, Netherlands)|May 15, 2025
Prognostic and predictive effects of TP53 co-mutation in patients with non-small cell lung cancer with rare treatable driver mutationsJamie Feng, Katrina Hueniken, Zhen Jason Fan, et al.
BMC Genomics|April 30, 2015
Whole-exome analysis of foetal autopsy tissue reveals a frameshift mutation in OBSL1, consistent with a diagnosis of 3-M SyndromeChristian R Marshall, Sandra A Farrell, Donna Cushing, et al.
Current Oncology (Toronto, Ont.)|August 28, 2024
Repeat Next-Generation Sequencing (15-Gene Panel) in Unifocal, Synchronous, and Metachronous Non-Small-Cell Lung Cancer-A Single-Center ExperienceShelley Kuang, Kaitlin Chen, Sachin Sayal, et al.
Plos One|December 1, 2021
Genomic characterization of non-schistosomiasis-related squamous cell carcinoma of the urinary bladder: A retrospective exploratory studyEsmail M Al-Ezzi, Zachary W Veitch, Samer H Salah, et al.
International Journal of Cancer|September 12, 2017
Identifying actionable variants using next generation sequencing in patients with a historical diagnosis of undifferentiated pleomorphic sarcomaJeremy Lewin, Swati Garg, Beatrice Y Lau, et al.
BMC Medical Genomics|August 11, 2018
Additional germline findings from a tumor profiling programNeda Stjepanovic, Tracy L Stockley, Philippe L Bedard, et al.
Current Oncology (Toronto, Ont.)|May 15, 2023
Consensus Recommendations to Optimize the Detection and Reporting of <i>NTRK</i> Gene Fusions by RNA-Based Next-Generation SequencingTracy L Stockley, Bryan Lo, Adrian Box, et al.
Breast Cancer Research and Treatment|November 28, 2017
Impact of multi-gene mutational profiling on clinical trial outcomes in metastatic breast cancerRossanna C Pezo, Tom W Chen, Hal K Berman, et al.
Journal of Medical Genetics|December 23, 2022
Development of a comprehensive approach to adult hereditary cancer testing in OntarioKathleen Anne Bell, Raymond Kim, Melyssa Aronson, et al.
Pageof 12